Medtronic and Philips Forge Strategic Partnership to Transform Stroke Care

Oct 25, 2024 17:44 CST Updated 17:44

Medtronic

Chronic Disease Medical Device and Therapy Developer

Philips

Healthcare Service Provider

Instrument Family

Pioneer in Medical Device Media Reports

Share Professional Medical Device Knowledge

Source:Instrument Family,Reproduction without authorization is prohibited, and reproduction is allowed 24 hours later.

October 25, 2024Medtronic and Philips Announce Strategic Advocacy Partnership Focused on Stroke Care.The two companies will work together to raise awareness of the potential health and economic benefits that timely diagnosis and treatment of stroke can bring to patients, families, and society, while further expanding and strengthening their partnership with the World Stroke Organization (WSO).

It is reported that this cooperation has three key focus areas, includingRaise public awareness of stroke symptoms and the importance of seeking timely medical care, by increasing the number of hospitals capable of treating strokes and providing training.To improve treatment accessibility, utilize advanced technology to create a comprehensive stroke care system that supports early diagnosis, effective treatment, and postoperative monitoring.

Focus on Stroke Care

Philips and Medtronic, plc. Reach Cooperation

It is reported that through this cooperation, Medtronic and Philips will jointly advocate raising awareness of the potential health and economic benefits that timely stroke diagnosis and treatment can bring to patients, families, and society.

Medtronic Neurovascular and Philips will further expand and strengthen their partnership with the World Stroke Organization (WSO).After joining the newly established World Stroke Organization Advocacy Coalition, the two parties will develop a coordinated strategy to address the burden of stroke. They will also collaborate with other stakeholders to share the latest research findings, exchange best practices, and drive improvements.

Medtronic stated: "Stroke care is a race against time,By partnering with Philips, we can help accelerate access to life-saving treatments like mechanical thrombectomy."Jointly advocate for the necessary investment in stroke care infrastructure to alleviate the burden on patients and healthcare systems worldwide."

It is reported that this cooperation has three key focus areas: first,Philips and Medtronic Aim to Raise Awareness. They aim to promote public understanding of stroke symptoms and the importance of seeking immediate care; secondly,Improving Access to Treatment by Expanding the Number of Stroke-Ready Hospitals and Providing Training; Finally,Hope to use advanced technology to create a comprehensive stroke care system.These systems support early diagnosis, effective treatment, and postoperative monitoring.

Chief Medical Officer of Philips Carla Goulart PeronSaid: "Our new collaboration with Medtronic's Neurovascular division and our ongoing partnership with the World Stroke Organization highlight our shared commitment to transforming stroke care."With advanced technology and a focus on collaboration, now is the time to act to ensure that stroke patients receive timely stroke care wherever they are.”

Medtronic's Layout in the Stroke Field

In the field of neurointervention, Medtronic is undoubtedly the global leader. According to data from the *Blue Book of China Medical Devices*, the market size for cerebrovascular intervention in 2018 was 4.8 billion yuan, showing a pattern of high concentration and foreign monopoly.Foreign brands occupy more than 80% of the market share in China, with Medtronic alone accounting for 60% of the market share, making it the leading company in the neurointervention industry.

Medtronic truly entered the global leading phase in the neurointerventional field starting from 2015, when it completed the acquisition of Covidien for $42.9 billion, marking the most notable merger and acquisition case in the history of the medical device industry at that time. Covidien had acquired ev3, a neurointerventional company founded in 2000, for $2.6 billion in 2010. Ev3 was a medical company focusing on interventional therapies, specializing in the cardiac peripheral and neurointerventional markets, and had developed a series of products including coils, balloons, microcatheters, and guidewires.

With the acquisition,Medtronic has successively introduced a variety of cutting-edge medical technologies and products, including liquid embolic systems, coils, intracranial vascular stents, intracranial thrombectomy stents, flow-diverting dense mesh stents, intracranial support catheters, balloons, microcatheters, and guidewires.

Currently, Medtronic's stroke solutions mainly include the following aspects:

Acute Ischemic Stroke Treatment

Medtronic's Solitaire™ Intracranial Thrombectomy Stent is a leading technology product in the field of endovascular treatment for acute ischemic stroke. The thrombectomy stent offers advantages such as rapid clot removal and restoration of blood flow, quickly restoring cerebral blood supply and helping achieve better treatment outcomes and prognosis for patients.

Between 2013 and 2018, this stent dominated or played a major role in up to 12 high-level studies. The results confirmed that its combined use with intravenous thrombolytic drugs (iv-tpa) can achieve better vascular recanalization rates for suitable patients with acute large vessel occlusive ischemic stroke and significantly improve functional outcomes.

Treatment of Hemorrhagic Stroke

Intracranial aneurysms are one of the common causes of hemorrhagic stroke and are also tumor-like bulges formed by localized abnormal changes in cerebral arterial vessels, which are prone to rupture and bleeding.

Blood Flow Diversion Therapy is MedtronicPipeline™Flex Flow Diverter StentInnovative Method for Treating Intracranial Aneurysms: Entering the Vessel from the Femoral Artery at the Groin, Placing a Stent in the Vascular Segment Where the Aneurysm is Located, Inducing Thrombosis Within the Aneurysm, and Forming a Biofilm at the Aneurysm Neck, achieving the purpose of occluding the aneurysm so that the aneurysm wall no longer bears the pressure of blood flow impact, thereby reducing the risk of recanalization and rupture. Compared with craniotomy clipping treatment and traditional interventional embolization treatment, it has the advantages of minimal trauma, quick recovery, and low surgical risk.

Monitoring and Symptom Support After Stroke

The Reveal Linq™ Insertable Cardiac Monitor can be used to monitor the heart condition of stroke patients, as cardiac issues are closely related to stroke.This monitor is an implantable, patient-activated and automatically activated monitoring system capable of recording subcutaneous electrocardiograms, which helps to timely detect cardiac abnormalities in patients and provides a basis for subsequent treatment.

Other Adjunctive Treatment Methods

Embolic Protection Device: A device used during endovascular procedures to capture and remove embolic material, reducing the risk of complications caused by the detachment of thrombi or other substances during surgery.

Drug Delivery System: Provide targeted drug delivery for stroke patients to ensure that the drug accurately reaches the lesion site, improving treatment efficacy.

Philips is a leader in stroke solutions.

October 2023,Philips announces a two-year partnership with the World Stroke Organization (WSO), based on a shared commitment to provide improved solutions in stroke prevention, treatment, rehabilitation, and support.Both parties will leverage their respective strengths to raise public awareness of stroke, a global health issue.

In fact, Philips, as a recognized leader in stroke solutions, has been committed to supporting rapid stroke treatment to minimize the impact on patients.Including stroke monitoring and communication solutions in ambulances, remote stroke patient assessment, artificial intelligence (AI) technology supporting diagnostic imaging and analysis, image-guided therapy, as well as neurological and cardiac monitoring and evaluation.At the same time, Philips alsoWith a fully integrated vascular suite system,To promote mechanical thrombectomy for stroke treatment.

It is worth mentioning that Philips alsoPhilips Announces Launch of Azurion Neuro Biplane System, Further Enhancing the Company's Azurion Series of Image-Guided Therapy Solutions.

It is reported that the new Azurion Neuro Biplane system is designed to advance and optimize the diagnosis and treatment process for stroke and neurovascular diseases. Equipped with 2D and 3D imaging technology, it ensures precise diagnosis and treatment.This system, used in conjunction with Philips' latest Neuro Suite software and services, provides neurointerventional physicians with a fully integrated solution.This solution encompasses Philips' ClarityIQ low-dose imaging technology and a dedicated series of tools and value-added services for neurology, offering unprecedented levels of efficiency, flexibility, and control.

In addition, the new features of the Azurion Neuro Biplane system include enhanced C-arm rotation & imaging angles, a device for rapid conversion from 2D to 3D imaging, and integrated tableside controls that reduce the frequency of leaving the sterile area.Automatic beam rotation for direct acquisition of images at various angles and a new head fixation device to support enhanced stroke care.

——

Stroke remains one of the most serious health challenges globally. According to a report from The Lancet,Stroke is the second leading cause of death globally, accounting for 12% of total deaths; it is estimated that by 2025, the global annual death toll from stroke will reach ten million.

Philips and Medtronic, as leaders in the stroke field, both companies have irreplaceable solutions and products.By integrating the advanced technologies and resources of both parties, it is expected to provide more timely and effective treatment for stroke patients, reducing the burden of stroke on patients and the healthcare system.

So, what kind of industry development trends will the collaboration between the two major medical giants trigger? In the future, how will the two companies jointly promote the advancement of stroke care technology? Instrument Family will continue to follow up.

END

1.774 Billion, Mindray Makes a Big Move

Mass Layoffs Begin? Where is SenseTime’s Medical Path Heading?

Imaging Giant: To Shut Down This Factory

GE Healthcare, Ultrasound Greater China Headquarters Established

GE Healthcare Launches the First CT Production Line in China

Omron China Region, Leadership Change

Industry Giants: Restructuring, Selling, Layoffs

China's Leading Respiratory Device Manufacturer Completes Major Acquisition

The latest generation of bioresorbable stents listed on the network, priced at 20,800 yuan

China's "Silicon Valley" to Build Largest Grade A Hospital

BusinessBusiness cooperation email: qxzj@landianyiliao.com